Home

Behandeling Demonteer bibliotheek cervical cancer markers onderpand brug adviseren

Currently available and potentially useful serum markers for cervical... |  Download Table
Currently available and potentially useful serum markers for cervical... | Download Table

Cervical cancer stem cell‑associated genes: Prognostic implications in cervical  cancer (Review)
Cervical cancer stem cell‑associated genes: Prognostic implications in cervical cancer (Review)

Cervical Cancer Cells Express Markers Associated with Immunosurveillance
Cervical Cancer Cells Express Markers Associated with Immunosurveillance

Biomarkers for Cervical Cancer | Download Table
Biomarkers for Cervical Cancer | Download Table

Markers of cancer stem cells of the female reproductive system | Download  Table
Markers of cancer stem cells of the female reproductive system | Download Table

First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical  Benefit, Tolerability and Tumor Markers | Anticancer Research
First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research

Fluorescence in Situ Hybridization Markers for Prediction of Cervical Lymph  Node Metastases - The American Journal of Pathology
Fluorescence in Situ Hybridization Markers for Prediction of Cervical Lymph Node Metastases - The American Journal of Pathology

Combining imaging- and gene-based hypoxia biomarkers in cervical cancer  improves prediction of chemoradiotherapy failure independent of intratumour  heterogeneity - eBioMedicine
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity - eBioMedicine

Tumor Markers - CA153/proGRP/CA242/PGI/PGII/Cy211 | Fapon Biotech Inc.
Tumor Markers - CA153/proGRP/CA242/PGI/PGII/Cy211 | Fapon Biotech Inc.

Frontiers | Diagnostic Strategies for Recurrent Cervical Cancer: A Cohort  Study | Oncology
Frontiers | Diagnostic Strategies for Recurrent Cervical Cancer: A Cohort Study | Oncology

Frontiers | Diagnostic Tumor Markers in Head and Neck Squamous Cell  Carcinoma (HNSCC) in the Clinical Setting | Oncology
Frontiers | Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting | Oncology

Cervical cancer stem cells and other leading factors associated with cervical  cancer development (Review)
Cervical cancer stem cells and other leading factors associated with cervical cancer development (Review)

PLOS ONE: Mitosis Is a Source of Potential Markers for Screening and  Survival and Therapeutic Targets in Cervical Cancer
PLOS ONE: Mitosis Is a Source of Potential Markers for Screening and Survival and Therapeutic Targets in Cervical Cancer

Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers

Diagnostic serum markers for cervical cancer in clinical use. | Download  Table
Diagnostic serum markers for cervical cancer in clinical use. | Download Table

Infiltrating T-cell markers in cervical carcinogenesis: a systematic review  and meta-analysis | British Journal of Cancer
Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis | British Journal of Cancer

Diagnostic serum markers for cervical cancer in clinical use. | Download  Table
Diagnostic serum markers for cervical cancer in clinical use. | Download Table

Guidelines for the Use of Tumor Markers in Cervical Cancer | Semantic  Scholar
Guidelines for the Use of Tumor Markers in Cervical Cancer | Semantic Scholar

Prognostic Cell Biological Markers in Cervical Cancer Patients Primarily  Treated With (Chemo)radiation: A Systematic Review - International Journal  of Radiation Oncology, Biology, Physics
Prognostic Cell Biological Markers in Cervical Cancer Patients Primarily Treated With (Chemo)radiation: A Systematic Review - International Journal of Radiation Oncology, Biology, Physics

Table I from CYFRA 21.1 in patients with cervical cancer: comparison with  SCC and CEA. | Semantic Scholar
Table I from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar

Table 1 from Guidelines for the Use of Tumor Markers in Cervical Cancer |  Semantic Scholar
Table 1 from Guidelines for the Use of Tumor Markers in Cervical Cancer | Semantic Scholar

DRH1 – a novel blood-based HPV tumour marker - eBioMedicine
DRH1 – a novel blood-based HPV tumour marker - eBioMedicine

Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that  Controls Stemness and Self-Renewal through Upregulation of HES1 | Clinical  Cancer Research
Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1 | Clinical Cancer Research

Putative biomarkers for cervical cancer: SNVs, methylation and expression  profiles - ScienceDirect
Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles - ScienceDirect

Gene expression profiling identifies the role of Zac1 in cervical cancer  metastasis | Scientific Reports
Gene expression profiling identifies the role of Zac1 in cervical cancer metastasis | Scientific Reports

Squamous cell carcinoma antigen reproducible marker and its  clinicopathological correlation with preinvasive and invasive cervical  cancer Singh M, Sachan P, Patel ML, Shyam R, Sachan R - Clin Cancer  Investig J
Squamous cell carcinoma antigen reproducible marker and its clinicopathological correlation with preinvasive and invasive cervical cancer Singh M, Sachan P, Patel ML, Shyam R, Sachan R - Clin Cancer Investig J

Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based  on Systems Biology Technologies - ScienceDirect
Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies - ScienceDirect